Litcius/Paper detail

Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

Rangi Kandane‐Rathnayake, Vera Golder, Worawit Louthrenoo, Yi‐Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue‐Fen Luo, Yeong‐Jian Jan Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, BMDB Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang‐Cheol Bae, Shereen Oon, Sean O’Neill, Fiona Goldblatt, Kristine Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Cherica Tee, Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, DaeYoung Yu, Chetan S. Karyekar, Chak Sing Lau, Julie A. Monk, Mandana Nikpour, Alberta Hoi, Eric F. Morand

2022The Lancet Rheumatology67 citationsDOI

Topics & Concepts

MedicineSystemic lupus erythematosusProspective cohort studyDiseaseMultinational corporationCohortInternal medicineCohort studyLupus erythematosusImmunologyAntibodyPolitical scienceLawSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesMultiple Sclerosis Research Studies
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study | Litcius